Cravens & Co Advisors, LLC
- SEC CIK
- 0001966116
- Latest filing
- Aug 12, 2026
NVO holding history
Novo Nordisk A S in every 13F filed by Cravens & Co Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVO overviewAll 13F holders of NVOFull Q2 2026 holdings
- Shares (Q2 2026)
- 23,681
- Value
- $1.14M
- % of portfolio
- 0.8%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 23,681 | $1.14M | 0.8% | −4,993−17.4% | Reduced | Holders |
| Q1 2026 | 28,674 | $1.05M | 0.7% | +19,588+215.6% | Added | Holders |
| Q4 2025 | 9,086 | $541.9K | 0.4% | −7,367−44.8% | Reduced | Holders |
| Q3 2025 | 16,453 | $913.0K | 0.6% | +7,243+78.6% | Added | Holders |
| Q2 2025 | 9,210 | $635.7K | 0.5% | +177+2.0% | Added | Holders |
| Q1 2025 | 9,033 | $627.3K | 0.5% | +1,210+15.5% | Added | Holders |
| Q4 2024 | 7,823 | $672.9K | 0.5% | −274−3.4% | Reduced | Holders |
| Q3 2024 | 8,097 | $964.1K | 0.7% | +128+1.6% | Added | Holders |
| Q2 2024 | 7,969 | $1.14M | 0.8% | −281−3.4% | Reduced | Holders |
| Q1 2024 | 8,250 | $1.06M | 0.9% | +85+1.0% | Added | Holders |
| Q4 2023 | 8,165 | $844.7K | 0.7% | −23−0.3% | Reduced | Holders |
| Q3 2023 | 8,188 | $744.6K | 0.7% | +72+0.9% | AddedConverted for a 2-for-1 split | Holders |
| Q2 2023 | 4,058 | $656.7K | 0.6% | −1,251−23.6% | Reduced | Holders |
| Q1 2023 | 5,309 | $844.9K | 0.8% | +3+0.1% | Added | Holders |
| Q4 2022 | 5,306 | $718.1K | 0.7% | – | No prior filing | Holders |